QuickView for zm447439 (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

1. Improving Generation of Cardiac Organoids from Human Pluripotent Stem Cells Using the Aurora Kinase …
2. The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorig…
3. Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways.
4. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enh…
5. The Aurora kinase inhibitor ZM447439 accelerates first meiosis in mouse oocytes by overriding the sp…

There were no clinical trials for zm447439